Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032.
The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.
“We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers,” Cardinal Health CEO Jason Hollar said.
Cardinal Health Reaffirms Fiscal 2027 Earnings Guidance
Alongside the agreement, Cardinal Health reaffirmed its non-GAAP earnings guidance for fiscal 2027.
The company continues to expect non-GAAP earnings per share growth of between 13% and 15%, corresponding to a range of $12.40 to $12.60 per share.
The guidance is based on adjusted fiscal 2026 results excluding the benefit recorded during fiscal 2026 from an IEEPA tariff refund.
Cardinal Health also maintained its longer-term guidance for non-GAAP earnings per share growth of between 12% and 14%.
The company said it may provide further updates when it reports its first-quarter results on November 5, 2026.